The effect of cost on adherence to prescription medications in Canada.
about
How payment scheme affects patients' adherence to medications? A systematic reviewUniversal prescription drug coverage in Canada: Long-promised yet undeliveredCanadian list of essential medications: Potential and uncertaintiesListe canadienne des médicaments essentiels: Potentiel et incertitudes.Medication access via hospital admission.L’accès aux médicaments par l’hospitalisationImpact of income-based deductibles on drug use and health care utilization among older adults.CETA and pharmaceuticals: impact of the trade agreement between Europe and Canada on the costs of prescription drugs.Estimated cost of universal public coverage of prescription drugs in CanadaHerpes zoster vaccine (HZV): utilization and coverage 2009 - 2013, Alberta, CanadaDelivering on the promise of Medicare.Persistent medication affordability problems among disabled Medicare beneficiaries after Part D, 2006-2011Policy versus practice: a community-based qualitative study of the realities of pharmacy services in Nunavut, Canada.Canadian pharmacare: looking back, looking forward.Financial barriers and adverse clinical outcomes among patients with cardiovascular-related chronic diseases: a cohort study.Exploring the impact of financial barriers on secondary prevention of heart disease.Universal drug coverage and socioeconomic disparities in major diabetes outcomesUse of Compassionate Supply of Antiretroviral Drugs to Avoid Treatment Interruptions or Delayed Treatment Initiation among HIV-Positive Patients Living in Ontario: A Retrospective Review.The Impact of Private Insurance Coverage on Prescription Drug Use in Ontario, Canada.Non-adherence in type 2 diabetes: practical considerations for interpreting the literatureThe potential exploitation of research participants in high income countries who lack access to health careA fresh perspective on comparing the FDA and the CHMP/EMA: approval of antineoplastic tyrosine kinase inhibitors.The road to competitive generic drug prices in Canada.Finding resiliency in the face of financial barriers: Development of a conceptual framework for people with cardiovascular-related chronic disease.Addressing cost-related barriers to prescription drug use in Canada.Cost-related non-adherence to prescribed medicines among older adults: a cross-sectional analysis of a survey in 11 developed countries.Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada.Provincial disparities of growth hormone coverage for young adult survivors of paediatric brain tumours across CanadaDevelopment of a preliminary essential medicines list for Canada.The effects of catastrophic drug plan deductibles on older women's use of cardiovascular medicines: a retrospective cohort study.Cost-related nonadherence to prescribed medicines among older Canadians in 2014: a cross-sectional analysis of a telephone survey.Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review.Drug adherence of patients with epilepsy in Iran: the effects of the international economic sanctions.Money left on the table: generic drug prices in Canada.Understanding Financial Barriers to Care in Patients With Diabetes.Potential contribution of lifestyle and socioeconomic factors to healthy user bias in antihypertensives and lipid-lowering drugs.Barriers to Prescription Medication Adherence Among Homeless and Vulnerably Housed Adults in Three Canadian Cities.Protocol for a randomised controlled trial evaluating the effects of providing essential medicines at no charge: the Carefully seLected and Easily Accessible at No Charge Medicines (CLEAN Meds) trial.A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada.Out-of-pocket costs and adherence to antihypertensive agents among older adults covered by the public drug insurance plan in Quebec.
P2860
Q26745601-BDBB51B0-4107-49D5-B0BE-80C02E1D560BQ28069734-08D09C8C-A826-477D-B916-0A14FF6185C9Q33558488-81FC5131-5272-4C23-AE65-57A59D8BC3D1Q33558544-D0C9D6CC-DE57-4BC1-B836-5E08DF47DB5BQ33675478-8024803A-9CD4-44B7-ADC6-7EB21B98F796Q33675487-18CCC3E3-3272-4F2B-A0B1-380104111C72Q33694182-2FECB499-E295-4D37-BC67-311DFEA145F0Q33939125-233D6B44-0CE0-42D8-ACCC-511ED1AABF96Q34467493-D879C233-6F53-4D43-85FA-9A971B859565Q34875123-8BBD097C-8146-4FBC-9915-FD3117362D7EQ35077070-6401AA79-9156-446B-A6A6-A1F13745E1C0Q35963348-F5E9C54A-F823-49C9-97D0-0090568122B1Q36076807-13268854-AB2C-40AB-B241-CDB47C265D8AQ36196926-634C3D09-683B-436A-BA3B-9E40B80BAB24Q36280399-1CC1F7DC-3266-4E33-A984-C7F43A710010Q36280419-3C97AE5B-A013-4F94-AEDB-25767A7C32B1Q36334609-4212EC4F-B3B3-402D-A4BE-4495DB504328Q36565336-C25A010F-9670-4B13-82A8-9B89A85D8665Q36565360-3494A149-7787-41F8-B512-170A5BDA2966Q36669031-15601E9A-2C1F-499A-AA97-3F90C162FFEBQ36806612-EBDA61CD-25A8-4B43-A5CC-D85F85BF5B4BQ37161896-880D6260-93FC-4B27-8E3E-39089E77305EQ37186277-6646CCB4-0B5E-425D-9F49-DB4FDC5FD2CEQ37606129-4B724AE5-0604-4FFC-B937-7129CF9628DDQ37614006-FB68C364-BD96-45F4-A431-FCE2F5A0D5D9Q37627254-4C2FD91C-E8AD-4333-8046-AF403ECAF268Q37666110-556F0A06-E400-44AD-BD26-0076E0A5E16CQ37723149-D47DD873-A7CF-4C1E-A77E-396B637F12B1Q37735852-8294F4DD-3B42-476F-B1E0-48D8E65249A8Q37735873-AAA213E1-79D2-47E5-9505-89F5ADB47483Q37735874-4D18E6BB-71EA-47AA-8A31-AF5E8166C92AQ38074481-CF4C374B-D897-4021-880D-090782352D66Q38600713-9E7E2BD9-C2AA-4D44-83A4-BCAED5916C6CQ38964167-587BB0AF-1A48-470B-BA46-6F20191C3C43Q39128642-628A7185-91B4-4790-9980-67B088C24A01Q40100271-D8980528-DFDA-4465-AE0E-89F44A799E8DQ40237513-5F02DEAE-DBCE-48F6-896B-825738D1A69EQ40478455-4E77D012-1F02-4ECA-92E1-E5B03C4E7D74Q40995361-FF00CDF6-D27A-4E6D-B559-9623440B9503Q41080901-9FF6CABF-2FBC-41D5-BF2F-3D8F95B64EA2
P2860
The effect of cost on adherence to prescription medications in Canada.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The effect of cost on adherence to prescription medications in Canada.
@ast
The effect of cost on adherence to prescription medications in Canada.
@en
type
label
The effect of cost on adherence to prescription medications in Canada.
@ast
The effect of cost on adherence to prescription medications in Canada.
@en
prefLabel
The effect of cost on adherence to prescription medications in Canada.
@ast
The effect of cost on adherence to prescription medications in Canada.
@en
P2093
P2860
P356
P1476
The effect of cost on adherence to prescription medications in Canada.
@en
P2093
Deborah Heard
Irfan A Dhalla
Lucy Cheng
Michael R Law
Steven G Morgan
P2860
P304
P356
10.1503/CMAJ.111270
P407
P577
2012-01-16T00:00:00Z